IPP Bureau
NIPER Raebareli–Roche tie-up signals big push for India’s pharma innovation future
By IPP Bureau - March 20, 2026
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
Pfizer reports breakthrough in advanced prostate cancer with TALZENNA Plus XTANDI
By IPP Bureau - March 20, 2026
The study hit its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) compared to placebo plus XTANDI
Zydus launches Aerolife Mini to simplify inhaler use for asthma and COPD patients
By IPP Bureau - March 20, 2026
India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease
Glenmark Therapeutics USA launches fluticasone propionate nasal spray
By IPP Bureau - March 20, 2026
The Flonase Allergy Relief Nasal Spray, 50 mcg per spray market achieved annual sales of approximately $384.7 million
Glenmark Pharmaceuticals USA launches authorized generic of Savella tablets
By IPP Bureau - March 20, 2026
Glenmark's Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg is the authorized generic to Savella Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg
Epigenica expands into Japan via PrimeTech partnership
By IPP Bureau - March 20, 2026
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
LANXESS marks 40 yrs of animal disease defense 'Virkon S'
By IPP Bureau - March 20, 2026
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
Clariant boosts US pharmaceutical production with Clear Lake expansion
By IPP Bureau - March 20, 2026
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
Biotium unveils ViaPlex 2-Color Cell Barcoding Kit to supercharge flow cytometry
By IPP Bureau - March 20, 2026
The kit features ViaPlex 405 Barcoding Dye for the 405 nm laser/Pacific Blue filter and ViaPlex 488 Barcoding Dye for the 488 nm laser/FITC filter
Pfizer drug candidate shows strong results in tough breast cancer study
By IPP Bureau - March 19, 2026
The drug also showed a manageable safety profile, with just 6.4% of patients stopping treatment due to side effects. No new safety concerns emerged
IIT Roorkee unveils cutting-edge molecular medicine facility
By IPP Bureau - March 19, 2026
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
Roche unveils massive AI factory to supercharge drug development
By IPP Bureau - March 19, 2026
The facility features 2,176 high-performance GPUs across the US and Europe
Alcon walks away from LENSAR deal after regulatory roadblock
By IPP Bureau - March 19, 2026
At the center of the collapse is opposition from the Federal Trade Commission
